Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
It is a non-interventional study with a duration of approximately 24 months per participant
to investigate the therapeutic efficiency, safety and treatment regimens of Rituximab
maintenance therapy in daily routine in participants with previously untreated, relapsed or
refractory cluster of differentiation 20 (CD20)-positive follicular lymphoma (FL) in clinical
practice.